Extensions of these findings suggest HIF2A-dependent induction of AREG in cardioprotection from ischemia, and implicate pharmacologic strategies that stabilize HIFs or promote AREG signaling in cardioprotection from ischemia and reperfusion injury. The gene discussed is AREG; the disease is ischemia.